Search filters

List of works by Andreas Schneeweiss

11q13 is a susceptibility locus for hormone receptor positive breast cancer

scientific article

13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).

scientific article

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

scientific article

15. Internationale St.-Gallen-Konsensus-Konferenz: Behandlung des frühen Mammakarzinoms

19p13.1 is a triple-negative-specific breast cancer susceptibility locus

scientific article published on 13 February 2012

9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium

scientific article published on 02 August 2012

A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial

scientific article

A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer

scientific article published in January 2005

ABC1 Consensus Conference - a German Perspective: First International Consensus Conference on Advanced Breast Cancer (ABC1), Lisbon, November 5, 2011.

scientific article published on 30 January 2012

Acceptance of oral chemotherapy in breast cancer patients - a survey study

scientific article

Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial ⬇️

scientific article published on July 16, 2013

Adjuvant Intensity Modulated Whole-Abdominal Radiation Therapy for High-Risk Patients With Ovarian Cancer (International Federation of Gynecology and Obstetrics Stage III): First Results of a Prospective Phase 2 Study

scientific article published on 4 July 2017

Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer.

scientific article

Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocol

scientific article

An Electronic Patient-Reported Outcome Tool for the FACT-B (Functional Assessment of Cancer Therapy-Breast) Questionnaire for Measuring the Health-Related Quality of Life in Patients With Breast Cancer: Reliability Study

article

Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study

scientific article published on 18 July 2017

Association analysis identifies 65 new breast cancer risk loci.

scientific article published on 23 October 2017

Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial

scientific article

Association of HER2 Overexpression and Prognosis in Small (T1N0) Primary Breast Cancers

scientific article published on June 2013

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium

scientific article published on 18 August 2011

Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

article by Xiang Shu et al published 1 October 2018 in International Journal of Epidemiology

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Biological subtypes of triple-negative breast cancer are associated with distinct morphological changes and clinical behaviour

scientific article published on 24 June 2013

Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network

scientific article

Breast cancer and diabetes mellitus

scientific article published on 08 June 2010

Breast cancer mastectomy trends between 2006 and 2010: association with magnetic resonance imaging, immediate breast reconstruction, and hospital volume.

scientific article published on 10 July 2013

Breast cancer presentation and therapy in migrant versus native German patients: contrasting and convergent data of a retrospective monocentric study

scientific article published on 4 November 2015

Breast cancers with a BRCA1-like DNA copy number profile recur less often than expected after high-dose alkylating chemotherapy

scientific article published on 5 December 2014

CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients

scientific article published in August 2016

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

scientific article published on 30 September 2011

Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?

scientific article

Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?

scientific article published on 4 November 2016

Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?

Carcinoma of Unknown Primary – an Orphan Disease? ⬇️

scientific article published on June 19, 2008

Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study

scientific article published on 26 June 2014

Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence

scientific article published on 24 April 2017

Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy

scientific article

Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression

scientific article published in November 2003

Chemotherapy for Metastatic Breast Cancer - An Anachronism in the Era of Personalised and Targeted Oncological Therapy?

scientific article published in June 2015

Chromothripsis in human breast cancer

scientific article published on 24 September 2020

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?

scientific article published on 18 December 2017

Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer

scientific article published on 16 January 2018

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer

scientific article

Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis

scientific article published on 19 January 2016

Circulating microRNAs in plasma as early detection markers for breast cancer

scientific article

Circulating tumor cells predict survival in early average-to-high risk breast cancer patients

scientific article

Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years

scientific article published on 22 December 2017

Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity

scientific article published on 9 May 2017

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients

scientific article

Combined Chemotherapy with Mitomycin C, Folinic Acid, and 5-Fluorouracil (MiFoFU) as Salvage Treatment for Patients with Liver Metastases from Breast Cancer – a Retrospective Analysis ⬇️

scientific article published on August 11, 2008

Common germline polymorphisms associated with breast cancer-specific survival

scientific article published on 22 April 2015

Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

scientific article

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients ⬇️

scientific article published on May 24, 2011

Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer

scientific article

Comparison of immunohistological parameters in primary breast cancers and corresponding locoregional recurrences

scientific article published on 3 February 2006

Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients

scientific article

Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer

scientific article

Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

scientific article published in PLoS ONE

Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system

scientific article published on 19 March 2010

Cost-utility analysis for advanced breast cancer therapy in Germany: results of the fulvestrant sequencing model

scientific article published on 8 January 2009

DNA methylation array analyses identified breast cancer-associatedHYAL2methylation in peripheral blood

DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.

scientific article published on 26 August 2016

Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial

scientific article

Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients

scientific article published on 14 December 2010

Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.

scientific article published on 10 May 2019

Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) - Recommendations for Daily Routine Practice.

scientific article published on 14 June 2019

Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment

scientific article

Dose-dense primary systemic chemotherapy with gemcitabine plus epirubicin sequentially followed by docetaxel for early breast cancer: final results of a phase I/II trial

scientific article

Dual Blockade with AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients with Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy-DAFNE (GBG-70).

scientific article published on 30 March 2015

Dual HER2-blockade with pertuzumab and trastuzumab in HER2-positive early breast cancer: a subanalysis of data from the randomized phase III GeparSepto trial

scientific article

Effects of distant metastasis and peripheral CA 15-3 on the induction of spontaneous T cell responses in breast cancer patients

scientific article published on 2 December 2009

Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69).

scientific article published on 17 March 2017

Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer

scientific article

Efficacy and toxicity profile of pegylated liposomal doxorubicin in patients with advanced ovarian cancer

scientific article published on 26 October 2015

Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients.

scientific article published on 07 August 2017

Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study

scientific article published on 27 February 2018

Estrogen-related receptor alpha expression and function is associated with the transcriptional coregulator AIB1 in breast carcinoma

scientific article

Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study

scientific article

Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals.

scientific article

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

scientific article

FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer

scientific article published on 10 February 2010

Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer ⬇️

scientific article

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2.

scientific article published on 4 February 2015

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

article

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

scientific article

First-line Bevacizumab-containing Therapy for HER2-negative Metastatic Breast Cancer: Final Results from a Prospective German Study

scientific article

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial ⬇️

scientific article published on August 24, 2010

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

scientific article published on 27 March 2013

Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study

scientific article published on November 2004

Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer

scientific article published in April 2006

Generalized lichen ruber planus--induced by radiotherapy of the breast?

scientific article published on 25 October 2006

Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study

scientific article published on 28 June 2017

Genetic predisposition to in situ and invasive lobular carcinoma of the breast

scientific article

Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk

scientific article published on 3 November 2010

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

scientific article

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade

scientific article

Genome-wide association analysis identifies three new breast cancer susceptibility loci

scientific article published on 22 January 2012

Genome-wide association studies identify four ER negative-specific breast cancer risk loci

scientific article published in April 2013

German Adjuvant Intergroup Node-positive Study (GAIN): A Phase III Trial Comparing Two Dose-Dense Regimens (iddEPC vs. ddEC-PwX) in High-Risk Early Breast Cancer Patients

scientific article

German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer

scientific article

Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial

scientific article

HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer

scientific article (publication date: March 2013)

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial ⬇️

scientific article published on September 22, 2010

Helical tomotherapy as a new treatment technique for whole abdominal irradiation

scientific article published in March 2008

Heterogeneity of miR-10b expression in circulating tumor cells

scientific article

How the Consolidated Framework for Implementation Research Can Strengthen Findings and Improve Translation of Research Into Practice: A Case Study

scientific article

Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic mice

scientific article

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

scientific article published on 21 April 2013

Identification of novel genetic markers of breast cancer survival

scientific article published on 18 April 2015

Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials

scientific article

Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

scientific article published on 11 September 2017

Impact of reproductive factors on breast cancer subtypes in postmenopausal women: a retrospective single-center study

scientific article published on 7 February 2017

Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry

scientific article published on 24 August 2017

In silico SNP analysis of the breast cancer antigen NY-BR-1.

scientific article

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab

scientific article published on 05 January 2017

Incorporating progesterone receptor expression into the PREDICT breast prognostic model

scientific article published in 2022

Induction of remission in a patient with metastatic breast cancer refractory to trastuzumab and chemotherapy following treatment with gefitinib ('Iressa', ZD1839).

scientific article published in March 2004

Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017).

scientific article published on 28 June 2017

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study

scientific article

Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer : four-year outcomes

scientific article

Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study

scientific article

Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer

scientific article

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Brea

Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer-Specific Immune Responses and Their Correlation to Prognosis

article

Intravenous pamidronate versus oral and intravenous clodronate in bone metastatic breast cancer: a randomized, open-label, non-inferiority Phase III trial

scientific article published on 08 July 2016

Intrinsic breast cancer subtypes defined by estrogen receptor signalling—prognostic relevance of progesterone receptor loss ⬇️

scientific article published on April 5, 2013

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

scientific article

Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-posit

scientific article published on 7 December 2017

Long-term remission of excessive liver metastases in a breast cancer patient with chronic alcohol abuse using a monotherapy with trastuzumab

scientific article published in February 2005

Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial

scientific article published on 18 April 2013

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

scientific article

Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working Group

scientific article published on 29 June 2015

Mcl-1 confers protection of Her2-positive breast cancer cells to hypoxia: therapeutic implications

scientific article

Mechanistic Investigations of Diarrhea Toxicity Induced by anti-HER2/3 Combination Therapy

scientific article published on 13 April 2018

Metabolic shifts in residual breast cancer drive tumor recurrence

scientific article published on 15 May 2017

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome ⬇️

scientific article published on September 14, 2011

MicroRNA related polymorphisms and breast cancer risk

scientific article

Molecular and clinical characterization of an in frame deletion of uncertain clinical significance in the BRCA2 gene ⬇️

scientific article published on January 8, 2012

Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients

scientific article published on 5 June 2015

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

scientific article published on April 2013

Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences

scientific article

Nab-Paclitaxel monotherapy as a treatment of patients with metastatic breast cancer in routine clinical practice

scientific article published on August 1, 2013

Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial

scientific article

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

scientific article

Neoadjuvant epirubicin, gemcitabine and docetaxel for primary breast cancer: Long‐term survival data and major prognostic factors based on two consecutive neoadjuvant phase I/II trials ⬇️

scientific article published on March 16, 2013

Neoadjuvant therapy with gemcitabine in breast cancer

scientific article

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

scientific article published in May 2015

Non-pegylated liposomal doxorubicin for patients with recurrent ovarian cancer: A multicentric phase II trial

scientific article published on 16 June 2016

Oblimersen combined with docetaxel, adriamycin and cyclophosphamide as neo-adjuvant systemic treatment in primary breast cancer: final results of a multicentric phase I study

scientific article published on 13 May 2008

Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations

scientific article published on 7 February 2013

Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy

scientific article published in February 2004

Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials

scientific article published on 26 February 2018

Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials

scientific article published on 5 September 2017

Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials

scientific article

Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit.

scientific article published on 5 February 2012

PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer

scientific article published on 8 September 2014

Parity improves anti-tumor immunity in breast cancer patients

scientific article published on 8 September 2017

Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications

scientific article published on 17 October 2016

Pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant, recurrent, pre-treated ovarian cancer - Results of the PACOVAR-trial

scientific article published on 18 May 2017

Personalized therapy in breast cancer

scientific article published on 20 January 2012

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA) ⬇️

scientific article published on May 22, 2013

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer

scientific article

Phase I study of apoptosis gene modulation with oblimersen within preoperative chemotherapy in patients with primary breast cancer.

scientific article published on 15 July 2009

Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer

scientific article published on 21 August 2006

Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III - The OVAR-IMRT-02 Study ⬇️

scientific article published on January 28, 2011

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

scientific article

Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer

scientific article published on 9 March 2009

Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis

scientific article published on 17 May 2014

Plasma S100P level as a novel prognostic marker of metastatic breast cancer

scientific article

Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer

scientific article published on 19 December 2015

Plasma microRNA panel for minimally invasive detection of breast cancer

scientific article

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

scientific article

Practical experiences with eribulin in patients with metastatic breast cancer

scientific article published in February 2016

Pre-Osteoblasts Stimulate Migration of Breast Cancer Cells via the HGF/MET Pathway

scientific article

Prediction of breast cancer risk based on profiling with common genetic variants

scientific article published on 8 April 2015

Predictors of Residual Tumor in Breast-Conserving Therapy

scientific article published on 30 July 2015

Predictors of resectability in breast-conserving therapy

scientific article published on 17 June 2012

Preoperative Systemic Treatment in BRCA-Positive Breast Cancer Patients: Case Report and Review of the Literature

scientific article

Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis

scientific article published on 01 April 2019

Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.

scientific article

Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer

scientific article published on 10 January 2017

Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015).

scientific article

Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgery

scientific article published on 20 July 2017

Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study

scientific article

Prognostic factors for patients with liver metastases from breast cancer

scientific article published in March 2006

Prognostic impact of hemoglobin levels before and during carboplatin/taxane-based chemotherapy in patients with primary invasive epithelial ovarian cancer

scientific article published in April 2009

Protein phosphatase 1, regulatory subunit 15B is a survival factor for ERα-positive breast cancer

scientific article published on 27 December 2012

Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

scientific article published on 10 April 2018

Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE).

scientific article published on 30 July 2017

Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer

scientific article published on 3 June 2013

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

scientific article published on 12 November 2007

Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.

scientific article published on 14 September 2017

Reply to S. Iwase et al.

scientific article published on 30 November 2015

Reprogramming of the ERRα and ERα target gene landscape triggers tamoxifen resistance in breast cancer

scientific article

Response-guided neoadjuvant chemotherapy for breast cancer

scientific article published on 3 September 2013

Reverse phase protein array based tumor profiling identifies a biomarker signature for risk classification of hormone receptor-positive breast cancer

S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer

scientific article published on 22 June 2015

Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective

scientific article

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients

scientific article

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study ⬇️

scientific article published on July 26, 2011

Smaller regional volumes of gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy

scientific article

Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro).

scientific article published on 21 November 2013

T-DM1 as a New Treatment Option for Patients with Metastatic HER2-positive Breast Cancer in Clinical Practice.

scientific article

Targeted Therapies in Triple-Negative Breast Cancer

scientific article

Targeted Therapy in Breast Cancer ⬇️

scientific article published on June 8, 2010

Targeted Therapy of HER2-Negative Breast Cancer

scientific article published on 10 February 2016

Targeted and immuno-biology driven treatment strategies for triple-negative breast cancer: current knowledge and future perspectives

article

Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance

scientific article published on 28 October 2016

Taxane-based palliative chemotherapy for metastatic breast cancer: matched pair analysis to compare the efficacy and safety of docetaxel and paclitaxel

scientific article published in September 2001

Ten-year Results of Intense Dose-dense chemotherapy show superior survival compared to a conventional schedule in High-risk Primary Breast Cancer: Final results of AGO Phase III iddEPC trial

scientific article published on 24 October 2017

The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use ⬇️

scientific article published on November 7, 2012

The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

scientific article published on 20 February 2018

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial

scientific article

The PACOVAR-trial: a phase I/II study of pazopanib (GW786034) and cyclophosphamide in patients with platinum-resistant recurrent, pre-treated ovarian cancer

scientific article

The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies

scientific article published on March 2017

The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer

scientific article published on 20 March 2017

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients

scientific article published on 14 May 2015

The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial

scientific article

The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer

scientific article published on 28 December 2012

The role of genetic breast cancer susceptibility variants as prognostic factors

scientific article

The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

scientific article

Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program

scientific article published on 9 September 2015

Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry

Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers

scientific article

Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial

scientific article

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

scientific article published on 14 February 2019

Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry

scientific article

Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study

scientific article

Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry

scientific article published on 19 May 2017

Tumor-Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

scientific article published on 7 December 2017

Update Breast Cancer 2017 - Implementation of Novel Therapies

scientific article

Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers

scientific article published on 21 March 2018

Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

scientific article published on 21 March 2018

Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer

scientific article published on 26 November 2018

Update Breast Cancer 2018 (Part 4) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer

scientific article published on 26 November 2018

Update Breast Cancer 2019 Part 1 - Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer

Update Breast Cancer 2019 Part 2 – Implementation of Novel Diagnostics and Therapeutics in Advanced Breast Cancer Patients in Clinical Practice

article published in 2019

Update Breast Cancer 2019 Part 3 – Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel

scientific article published on 21 May 2019

Use of complementary and integrative medicine among German breast cancer patients: predictors and implications for patient care within the PRAEGNANT study network

scientific article

Use of trastuzumab beyond disease progression: observations from a retrospective review of case histories

scientific article published on April 2004

Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians

Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy

scientific article published on 13 December 2015

Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study

scientific article published on September 2007

Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients

scientific article

Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29).

scientific article published on 17 June 2016

Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer).

scientific article

pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials

scientific article

rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

scientific article

Änderungen der Stadiengruppierung und Überlebensraten bei Anwendung der neuen TNM-Klassifikation für das Mammakarzinom

scientific article published in September 2004

Paulina is supported by:

About Paulina

Help